Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear Medicine
SEATTLE, Oct. 23, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that […]